histamine has been researched along with Multiple System Atrophy in 2 studies
Multiple System Atrophy: A syndrome complex composed of three conditions which represent clinical variants of the same disease process: STRIATONIGRAL DEGENERATION; SHY-DRAGER SYNDROME; and the sporadic form of OLIVOPONTOCEREBELLAR ATROPHIES. Clinical features include autonomic, cerebellar, and basal ganglia dysfunction. Pathologic examination reveals atrophy of the basal ganglia, cerebellum, pons, and medulla, with prominent loss of autonomic neurons in the brain stem and spinal cord. (From Adams et al., Principles of Neurology, 6th ed, p1076; Baillieres Clin Neurol 1997 Apr;6(1):187-204; Med Clin North Am 1999 Mar;83(2):381-92)
Excerpt | Relevance | Reference |
---|---|---|
"Compared with healthy controls, significant reduction of histaminergic neurons was found both in multiple system atrophy (total estimated cell count, 94,677 ± 5,521 vs." | 7.81 | Histaminergic tuberomammillary neuron loss in multiple system atrophy and dementia with Lewy bodies. ( Benarroch, EE; Low, PA; Parisi, JE; Schmeichel, AM, 2015) |
"We investigated histamine concentration in post-mortem brain samples of patients with Parkinson's disease (PD, n = 24), multiple system atrophy (MSA, n = 8) and age-matched controls (n = 27)." | 7.71 | Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy. ( Anichtchik, OV; Eriksson, KS; Kalimo, H; Kaslin, J; Panula, P; Rinne, JO; Röyttä, M; Tuomisto, L, 2002) |
"Compared with healthy controls, significant reduction of histaminergic neurons was found both in multiple system atrophy (total estimated cell count, 94,677 ± 5,521 vs." | 3.81 | Histaminergic tuberomammillary neuron loss in multiple system atrophy and dementia with Lewy bodies. ( Benarroch, EE; Low, PA; Parisi, JE; Schmeichel, AM, 2015) |
"We investigated histamine concentration in post-mortem brain samples of patients with Parkinson's disease (PD, n = 24), multiple system atrophy (MSA, n = 8) and age-matched controls (n = 27)." | 3.71 | Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy. ( Anichtchik, OV; Eriksson, KS; Kalimo, H; Kaslin, J; Panula, P; Rinne, JO; Röyttä, M; Tuomisto, L, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benarroch, EE | 1 |
Schmeichel, AM | 1 |
Parisi, JE | 1 |
Low, PA | 1 |
Rinne, JO | 1 |
Anichtchik, OV | 1 |
Eriksson, KS | 1 |
Kaslin, J | 1 |
Tuomisto, L | 1 |
Kalimo, H | 1 |
Röyttä, M | 1 |
Panula, P | 1 |
2 other studies available for histamine and Multiple System Atrophy
Article | Year |
---|---|
Histaminergic tuberomammillary neuron loss in multiple system atrophy and dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Female; Histamine; Humans; Lewy Body Disease; Male; Mammillary Bodies; Midd | 2015 |
Increased brain histamine levels in Parkinson's disease but not in multiple system atrophy.
Topics: Aged; Brain; Brain Chemistry; Female; Globus Pallidus; Histamine; Humans; Immunohistochemistry; Male | 2002 |